103 related articles for article (PubMed ID: 19793253)
21. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity.
Peled N; Shitrit D; Bendayan D; Peled E; Kramer MR
Respiration; 2007; 74(1):50-5. PubMed ID: 16954652
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
23. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
25. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
Hwang JY; Lee KY; Rhim JW; Youn YS; Oh JH; Han JW; Lee JS; Burgner D
Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
[TBL] [Abstract][Full Text] [Related]
26. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
Salven P; Orpana A; Joensuu H
Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
[TBL] [Abstract][Full Text] [Related]
27. [Kawasaki syndrome].
Schaad UB; Odermatt K; Stocker FP; Weber JW; Wedgwood J
Schweiz Med Wochenschr; 1990 Apr; 120(15):539-47. PubMed ID: 1692423
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor gene haplotypes in Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Ottenkamp J; Kuipers IM; Lam J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Arthritis Rheum; 2006 May; 54(5):1588-94. PubMed ID: 16645995
[TBL] [Abstract][Full Text] [Related]
30. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.
Fukunishi M; Kikkawa M; Hamana K; Onodera T; Matsuzaki K; Matsumoto Y; Hara J
J Pediatr; 2000 Aug; 137(2):172-6. PubMed ID: 10931407
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
Sangtawesin C; Kirawitaya T; Layangkool T; Nawasiri W; Vimolsarawong N
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
[TBL] [Abstract][Full Text] [Related]
33. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
34. An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome.
Eguchi T; Nomura Y; Hashiguchi T; Masuda K; Arata M; Hazeki D; Ueno K; Nishi J; Kawano Y; Maruyama I
Pediatr Infect Dis J; 2009 Apr; 28(4):339-41. PubMed ID: 19238112
[TBL] [Abstract][Full Text] [Related]
35. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.
Nomura Y; Masuda K; Maeno N; Yoshinaga M; Kawano Y
Int Arch Allergy Immunol; 2004 Oct; 135(2):161-5. PubMed ID: 15345916
[TBL] [Abstract][Full Text] [Related]
38. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
Callinan LS; Tabnak F; Holman RC; Maddox RA; Kim JJ; Schonberger LB; Vugia DJ; Belay ED
Pediatr Infect Dis J; 2012 Sep; 31(9):894-8. PubMed ID: 22565293
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
40. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
